Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.
about
Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticityImpact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-tolyl)guanidine in mouse and rat cultured hippocampal pyramidal neurones.Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathwayIntracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders.Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose.The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission.Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice.MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.Rewarding effects elicited by the microinjection of either AMPA or NMDA glutamatergic antagonists into the ventral tegmental area revealed by an intracranial self-administration paradigm in mice.
P2860
Q24649613-6BF9D3B8-D34D-40E6-B660-DE644FDE858EQ30406145-2451B6A8-3964-4694-A7F5-680F5B429ADFQ33921280-C10CF8DE-83FF-4B06-9E4C-CF17EEC14AF5Q34466181-3E80C209-3790-4813-B6C1-D029706AD237Q35748576-8AD0D006-F094-4794-9803-73018EAE3A2CQ36329691-BAAAE06B-24CE-4936-8787-B36C74DB08DAQ36877274-5803D883-3464-49AE-8C9D-2CE5C64D7D4EQ38301802-9878D8C5-3C55-44D1-ACAA-989A27CFC26FQ39758341-2270E517-E1E7-418C-85A5-CF95D8FC4ED1Q46296210-FFC580CA-E00D-4D1D-A82D-77EF6E2A4B99Q46764650-073ABAE1-B4B8-4DFA-8CAE-BECBA296F866Q47448107-6CD3B289-24D8-496B-91F2-3675B0BF9BC1Q47633556-79A0DF86-6F47-4E77-A3E7-6020E8C814FEQ48906983-E64E09A2-B923-43A8-B12D-166A9B4A7CB5Q52184216-60938203-B806-42EB-AD82-9CBDF89092A5
P2860
Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@en
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@nl
type
label
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@en
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@nl
prefLabel
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@en
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@nl
P1433
P1476
Non-competitive N-methyl-D-asp ...... egmental A10 dopamine neurons.
@en
P2093
P304
P356
10.1016/0304-3940(90)90823-R
P407
P577
1990-11-01T00:00:00Z